Skip to main content
Download PDF

An equity evaluation in stroke inpatients in regard to medical costs in China: a nationwide study

BMC Health Services Research volume 21, Article number: 425 (2021) Cite this article

Abstract

Background

Stroke has always been a severe disease and imposed heavy financial burden on the health system. Equity in patients in regard to healthcare utilization and medical costs are recognized as a significant factor influencing medical quality and health system responsiveness. The aim of this study is to understand the equity in stroke patients concerning medical costs and healthcare utilization, as well as identify potential factors contributing to geographic variation in stroke patients’ healthcare utilization and costs.

Methods

Covering 31 provinces in mainland China, our main data were a 5% random sample of stroke claims from Urban Employees Basic Medical Insurance (UEBMI) and Urban Residents Basic Medical Insurance (URBMI) from 2013 to 2016. The Theil index was employed to evaluate the equity in stroke patients in regard to healthcare utilization and medical costs, and the random-effect panel model was used to explore the impact of province-level factors (health resource factors, enabling factors, and economic factors) on medical costs and health care utilization.

Results

Stroke patients’ healthcare utilization and medical costs showed significant differences both within and between regions. The UEBMI scheme had an overall lower Theil index value than the URBMI scheme. The intra-region Theil index value was higher than the inter-region Theil index, with the Theil index highest within eastern China, China’s richest and most developed region. Health resource factors and enabling factors (represented by reimbursement rate and education attainment years) were identified significantly associated with medical costs (P < 0.05), but have no impact on average length of stay.

Conclusions

China’s fragmented urban health insurance schemes require further reform to ensure better equity in healthcare utilization and medical costs for stroke patients. Improving education attainment, offering equal access to healthcare, allocating health resources reasonably and balancing health services prices in different regions also count.

Peer Review reports

Background

With characteristics of high morbidity, high recurrence rate, high disability rate and high mortality, stroke remains the second leading cause of death and a major cause of disability worldwide, imposing a heavy financial burden to health system [1]. It was reported that western countries spent approximately 3 to 4% of total health care expenditures on stroke [2]. And in China, the newest evidence showed that nearly 2% of total health expenditures of urban residents were spent on stroke-related medical costs [3]. Previous studies have assessed medical costs for stroke patients in some specific cities in China: In Guangzhou, the average medical costs was $3212.1 from 2006 to 2013 [4], and it was calculated as $3052.7 in Beijing city in 2012 [5]. It seemed that geographic variation in stroke patients’ medical costs widely existed in China. While we know little about the level of fairness/unfairness on stroke patients’ medical costs.

As a common pursuit of human society, equity has attracted increasing attention from the public, and was considered as one of the main issues in the healthcare system [6, 7]. Equity in patients in regard to healthcare utilization and medical costs has always been recognized as significant factors influencing medical quality and health system responsiveness [8]. Improved equity in medical costs and healthcare utilization can contribute to mitigation of disparities in health care access for stroke patients from different regions. In order to promote equity in healthcare, the Chinese government has established a large and well-functioning social health insurance system, including two insurance schemes designed exclusively for urban residents: Urban Employee Basic Medical Insurance scheme (UEBMI) for the urban employed and the Urban Resident Basic Medical Insurance scheme (URBMI) for primary and secondary school students, children and other urban unemployed residents [9]. The two schemes covered roughly 750 million, or 54%, of the total Chinese population in 2016 [10]. The healthcare system was considered to have made substantial progress in improving equal access to care and strengthening financial protection in the past few decades [11]. The major differences between UEBMI and URBMI lie in source of funding, reimbursement rate, reimbursement ceiling and benefit packages. Since UEBMI is funded both by employers (2% of wages) and employees (6% of annual wages) [12], the revenue for URBMI is from individual premium contributions and subsides from central and local government. In 2016, the per-capita fund of UEBMI was $523.7, and $94.3, for URBMI. Usually, patients with UEBMI enjoy a higher reimbursement rate than the URBMI patients, which means UEBMI provides better financial protection than URBMI. In addition, UEBMI offers a more comprehensive coverage than URBMI, which focuses on inpatient services and catastrophic illness, but with limited coverage of basic outpatient services [13]. In addition, the reimbursement ceiling of a UEBMI patient was set as six times of local employees’ annual average wage per year, while six times of local household disposable income per year for a URBMI patient.

After implementation plans from provincial governments, UEBIM and URBMI were risk pooled across 333 municipalities (Beijing, Chongqing, Tianjin, Shanghai) and prefectures (administrative units within a province), which implies that there are approximately 333 different UEBMI schemes and URBMI schemes in the country [14]. Disparities exist in the benefit package, reimbursement rate and reimbursement ceiling within each local UEBMI and URBMI scheme [14]. Previous studies have identified that the UEBMI beneficiaries utilized more health services and had higher medical costs than those with URBMI [3, 4]. But we still don’t know whether there were disparities in equity in patients’ medical costs and healthcare utilization between UEBMI and URBMI in major diseases such as stroke. Have UEBMI stroke patients been experiencing greater equity than URBMI patients?

The equity in patients in regard to health expenditures has attracted the interests of many scholars in the field of public health. Various methods were adopted to conduct the research on equity in patients in regard to health expenditure, such as concentration index and Lorenz curve [15], Gini-coefficient [16], Theil index [17,18,19] and so on. Especially the Theil index, which was a useful tool used worldwide to measure equity, not only in China, but also in Ethiopia [18], India [20], and Bangladesh [21]. In this study, we used Theil index to measure the equity in the UEBMI and URBMI stroke patients in regard to medical costs and healthcare utilization, as well as to compare which insurance scheme was fairer. Further, we discussed the provincial-level factors influencing the geographical variation of stroke patients’ healthcare utilization and medical costs. Our findings are expected to provide possible advice for promoting equity in stroke patients’ medical costs, and most importantly, to provide new evidence for optimizing China’s fragment social health insurances schemes.

Methods

Data resources and regional division

We collected a 5% random sample of UEBMI and URBMI insured stoke inpatients’ claim data between January 1, 2013 to December 31, 2016. And supporting data were from the China Labor Statistics Yearbook 2014–2017, the China Health Statistics Yearbook 2014–2017 and the China Statistical Yearbook 2014–2017. Inpatients data were covered by all 31 provinces, and municipalities of mainland China, excluding Macao, Hong Kong and Taiwan. Based on their gross domestic product (GDP) per capita, the 31 provinces were categorized into three groups, the eastern, central and western regions. The eastern region, including Beijing, Tianjin, Hebei, Liaoning, Shanghai, Jiangsu, Zhejiang, Shandong, Guangdong, and Hainan, had, on average, the highest average GDP per capita; the central region, including Shanxi, Jilin, Heilongjiang, Anhui, Jiangxi, Henan, Hubei and Hunan, had the next highest average per capital GDP; and the western region, including Inner Mongolia, Guangxi, Chongqing, Sichuan, Guizhou, Yunnan, Tibet, Shanxi, Gansu, Qinghai, Ningxia, Xinjiang, had the lowest average per capita GDP.

Measuring tool

The Theil index is a relative indicator measure of economic and other types of inequality [22]. The advantage of the Theil index is that it can calculate the contribution of intra-group and inter-group inequities to total inequities, thus avoiding the calculation of absolute values. The Theil index ranges between 0 and 1, where smaller values point to more equitable distribution of some economic phenomena, such as income, across a population [23]. While originally used to measure inequalities in economic data, the Theil index is increasingly used to evaluate (in) equities in health services, including healthcare utilization and health service expenses [18]. The Theil index formula is:

$$ T=\sum \limits_{i=1}^N{p}_i{r}_i\ln \left({r}_i\right) $$
(1)

where Pi is the proportion of the population of province i, ri is the ratio of the health indicator prevalence in province i to the overall health indicator prevalence in the population. While the Theil index has another form to measure the inequality between different groups [24]. Since we divided the 31 provinces into three regions, the Theil index in formula (1) can also be decomposed into the Tintra, which measures utilization/expenditure inequality “within region”

$$ {T}_{intra}=\sum \limits_{i=1}^k{P}_g{T}_g $$
(2)

where Pg is the proportion of insured population in one region accounting for the total insured population and Tg is the Theil index of one region (eastern, central and western China). The Theil index (1) can also be decomposed into Tinter, which measures utilization/expenditure inequality “between regions”.

$$ {T}_{inter}=\sum \limits_{i=1}^k{P}_g\mathit{\log}\frac{P_g}{Y_g} $$
(3)

where Yg is the proportion of healthcare utilization/expense in one region accounting for the total healthcare utilization/expense. Higher Tintra and Tinter index values mean greater unfairness, while lower index values mean more equality.

$$ T={T}_{intra}+{T}_{inter} $$
(4)

The total Theil index value which reflects the level of equity in stroke patients in regard to medical costs/healthcare utilization in the whole country equals to the sum of Tintra and Tinter. Similarly, higher T index values mean greater inequity and vice versa.

Main indicators and statistical analysis

The Theil index was calculated with two indicators of expenses, medical costs (average direct medical costs for stroke patients in one province in one year) and OOP expenses (average share of medical costs paid by stroke patients in one province in one year), and one indicator of healthcare utilization, measured as average length of stay (ALOS). Based on the study framework of Anderson’s healthcare utilization model [19], results of previous studies and data availability, we chose health resource factors, enabling factors facilitating healthcare-seeking, and economic factors to explore the potential factors influencing geographic variation of stroke patients’ healthcare utilization and medical costs [25,26,27,28]. The independent variables and dependent variables are all at provincial level. In our study, the health resource factors contain two aspects: the number of healthcare staff per 1000 residents (Staff) and the number of actual open beds per 1000 residents (Beds). These data were obtained from the China Health Statistics Yearbook 2014–2017. The enabling factors facilitating or impeding the use of healthcare services comprised the regional reimbursement rate, regional average education attainment years and regional urban employment rate (the proportion of urban workers accounting for all the urban residents in a province). The economic factors were represented by the insurance fund per capita, measured by the total health insurance revenue divided by the insured population in that year, and GDP per capita. These data were collected from the China Labor Statistics Yearbook 2014–2017 and the China Statistical Yearbook 2014–2017. The average annual RMB-US exchange rate was used from 2013 to 2016, which was US$0.159.

Descriptive statistics were employed to illustrate the regional distribution of medical costs and healthcare utilization for stroke patients. After conducting Hausman test, the influencing factors were identified using panel time-series model with a random effect. Statistical analyses were conducted using STATA version 14.0 (Stata Corp LP, College Station, TX), with statistical significance α = 0.05.

Results

Regional distribution of medical costs and utilization for stroke inpatients in 2016

To assess equity in the regional distribution of medical costs and healthcare utilization for stroke patients, we made a detail calculation of medical costs, OOP expenses, and ALOS in each of the 31 provinces and municipalities and in each of the three regions. As shown in Table 1, there were significant differences in patients’ healthcare utilization and expenditure between regions, within regions and between provinces. For example, within the eastern region, Beijing had higher UEBMI medical costs (RMB21793.1/$3465.1) than all other eastern provinces, except Zhejiang (RMB26955.3/$4285.8); higher OOP expenses (RMB4611.8/$733.3) except for Tianjin (RMB5439.9/$864.9); and higher ALOS (16.2 days) except Zhejiang (27.8 days), Shanghai (26.5 days) and Guangdong (18.7 days). Within the central region, Hunan had the highest UEBMI medical costs (RMB 23804.2/$3784.9), OOP expenses (RMB 6111.3/$971.7) and URBMI OOP expenses (RMB5915.8/$940.6) than any other central provinces. Jiangxi had the highest URBMI medical costs (RMB12074.4/$1919.8) among central provinces. Within western China, in the UEBMI group, Qinghai had the highest medical costs (RMB 18432.0/$2930.7) and in Xinjiang, it was the lowest (RMB 7629.2/$1213.0). Guizhou had the lowest OOP expenses (RMB1584.2/$251.9 but the longest ALOS (20.3 days) among western provinces. While in the URBMI group, Xizang had the highest medical costs (RMB 27833.0/$4425.4) and OOP expenses (RMB10479.3/$1666) than all other western provinces.

Table 1 Regional distribution of healthcare utilization for UEBMI and URBMI stroke inpatients in 2016
Full size table

Within region hospital expenses and utilization rates in Table 1 point to significant inequalities in healthcare within region, between regions and between provinces.

Theil index of healthcare utilization and medical costs for stroke inpatients

The Theil index values in Table 2 show that there were significant variations in medical costs, OOP expenses and ALOS under both UEBMI and URBMI. As shown in Table 2, the year-by-year UEBMI Theil index of hospital cost fluctuated significantly, from 0.1256 in 2013 to 0.1700 in 2014, then back to 0.1214 in 2016. While the URBMI hospital cost index fluctuated up and down year-by-year, URBMI ALOS index rose every year. To further capture changes in the Theil index between UEBMI and URBMI, Table 2 calculates the difference of the Theil index values between UEBMI and URBMI, which shows that with higher numbers of Theil index values, the URBMI inpatients suffered greater unfairness in medical cost and health care utilization than the UEBMI inpatients. Second, the differences in Table 2 also show that these differences varied significantly year-by-year.

Table 2 Theil index of healthcare utilization and medical costs for stroke inpatients from 2013 to 2016
Full size table

An alternative illustration of inequalities in expenses and utilization is shown in Figs. 1, 2 and 3, which plots for each region the year-by-year Theil index for URBMI and UEBMI expenses and utilization. In the UEBMI and URBMI group, the eastern region had the highest Theil index of medical costs, OOP expenses, and ALOS over the four years, and the highest Theil index values between regions. The central and western region Theil index values were broadly similar, but displayed some, mainly small, different year-by-year fluctuations. The inter-region inequality indexs in Figs. 1, 2 and 3 show significant year-by-year fluctuations for UEBMI expenses and utilization, with the inter-region URBMI showing a more dampened year-by-year fluctuations in expenses and utilization. There were no significant trends in Figs. 1, 2 and 3 towards greater equality of hospital expenses and utilization within regions, between regions and between UEBMI and URBMI.

Fig. 1
figure 1

Theil index of medical costs from 2013 to 2016. Four curves in each subfigure denote the Theil index values within eastern, central and western China, and Theil index values between the three regions. X-axis represents the year and Y-axis denotes the Theil index value which was calculated by the formula (2) and (3) mentioned above. The right-side denotes the URBMI group and the left-side denotes Theil index values of the UEBMI group

Full size image
Fig. 2
figure 2

Theil index of OOP expenses from 2013 to 2016. Four curves in each subfigure denote the Theil index values within eastern, central and western China, and Theil index values between the three regions. X-axis represents the year and Y-axis denotes the Theil index value which was calculated by the formula (2) and (3) mentioned above. The right-side denotes the URBMI group and the left-side denotes Theil index values of the UEBMI group

Full size image
Fig. 3
figure 3

Theil index of ALOS from 2013 to 2016. Four curves in each subfigure denote the Theil index values within eastern, central and western China, and Theil index values between the three regions. X-axis represents the year and Y-axis denotes the Theil index value which was calculated by the formula (2) and (3) mentioned above. The right-side denotes the URBMI group and the left-side denotes Theil index values of the UEBMI group

Full size image

Factors associated with medical costs and healthcare utilization

The random-effect panel model explored the provincial level factors influencing the geographical variation of stroke patients’ healthcare utilization and expenditure. We found that the health resource factors and enabling factors (average schooling year and regional reimbursement rate) had significant influence on patients’ medical costs and OOP expenses, while the impact effect varied by insurance type. As shown in Table 3, for medical cost, the coefficient of number of actual open beds per 1000 residents was − 0.089 (P < 0.001) in the UEBMI group, while it was − 0.128 (P < 0.001) in the URBMI group, which means number of hospital beds had significant negative impact on stroke patients’ medical costs and URBMI group was more sensitive to the number of hospital beds. The coefficients of number of healthcare staff per 1000 residents was 0.087 (P < 0.001) in the UEBMI group while it was 0.113 (P < 0.001) in the URBMI group, which means the number of healthcare staff was positively associated with medical cost. In terms of enabling factors, if the average schooling year increases by 1 year, medical costs in the UEBMI group will decrease by 12.9%, and will decrease by 18.3%, in the URBMI group. The reimbursement rate was negatively (Coef. = − 0.009, P = 0.004) associated with medical costs in URBMI group. For OOP expenses, the number of health care staff and GDP per capita had positive influence on OOP expenses both in UEBMI and URBMI group. While the number of hospital beds, average schooling year and reimbursement rate all were negatively associated with OOP expenses both in UEBMI and URBMI group (P < 0.05). However, factors except fund per capita were all identified no significant on stroke patients’ healthcare utilization.

Table 3 Province-level factors associated with stroke inpatients’ medical costs and healthcare utilization.
Full size table

Discussion

For urban insurance schemes, this study provides a comprehensive nationwide exploration of equity in stroke patients’ healthcare utilization and expenses. Using the Theil index to measure “horizontal equity”, we found significant unfairness in stroke patients’ healthcare utilization and hospital expenses. The Theil index values in our study were significantly higher than Theil index values of government health care expenditure from 2013 to 2016, which were reported to range from 0.020 to 0.021(3). Theil index of health expenditure per capita in China, which ranged from 0.0583 to 0.0686 between 2013 and 2016 [29], also lower than Theil index value of stroke patients’ medical costs and healthcare utilization.

Inequity in stroke patients in regard to healthcare utilization kept growing

A steady rise in the Theil index of ALOS both in UEBMI and URBMI group, indicated the growing inequity in ALOS. For all patients in China, Xie et al. [30] also found that the overall equity in patients in regard to healthcare utilization declined from 2011 to 2015. In general, declining equity in UEBMI and URBMI ALOS might be attributable to economy development gap and local hospitals administration disparities, etc. Since ALOS was one of the important performance assessment indexes, public hospitals in China actively reduced patients’ ALOS, by encouraging, for example, patients to be discharged early, to improve their performance [31]. Previous studies reported that multimorbidity, specifically hypertension, was a strong predictor of longer ALOS for stroke patients [32]. There were considerable geographic variations in prevalence of hypertension in China, and high hypertension prevalence zones, which extended from parts of the southeast to the northern and northeast [33, 34]. These different geographical hypertension prevalence zones would impact the geographical utilization rates of UEBMI and URBMI in Table 1. We also expect that difference of regional stroke prevention and treatment systems was an important factor leading to the geographic variation in patients’ ALOS. Under a well-functioning stroke prevention and treatment system, stroke patients could receive more accessbile and higher quality treatment in high-level hospitals than other regions with relative weaker stroke prevention and treatment systems. Delayed medical checks and treatment, and the limited treatment capacity of a hospital, could dramatically contribute to longer ALOS for stroke patients [35, 36]. Previous studies noted the large geographic variation in stroke prevention and treatment system in China [1], which may explain some of the inequity in stroke patients in regard to healthcare utilization. We recommend that public hospitals in China establish an unified and more scientific assessment index system for stroke patients and improve their capacity for treating stroke patients. The government should further strengthen the stroke prevention and treatment system, especially in poor areas with diminished healthcare delivery.

The UEBMI stroke patients enjoyed greater fairness in medical costs and healthcare utilization than the URBMI patients

In this study, we emphasized on comparing fairness of patients’ medical costs and healthcare utilization by different insurance schemes. Our empirical evidence clearly revealed that the UEBMI group had an overall smaller Theil index of medical costs, OOP expenses and ALOS than the URBMI group from 2013 to 2016. That means stroke patients with URBMI experienced greater inequity in healthcare utilization and expenditure than those with UEBMI. Examining the equity in patients in regard to health service utilization in different regions, Zhang [37] also found patients covered by UEBMI had greater equity in healthcare utilization than those covered by URBMI. The UEBMI scheme provided more generous benefits, more comprehensive service coverage, as well as stronger financial protection [14]. Since the UEBMI scheme provided stronger financial protection than the URBMI scheme, UEBMI patients would seek a more comprehensive treatment than the URBMI patients [38]. With lower levels of benefits and financial protection, the URBMI patients would economize on their level of health services utilization subject to their family’s financial status [38]. This would contribute to inequity in healthcare utilization and hospital expenses. Importantly, patients covered by UEBMI had stable incomes due to their employment status and usually had a better financial situation than URBMI unemployed, retirees, students and children inpatients. Without worrying about the occurrence of catastrophic health expenditure, patients in different regions would receive treatment as required, but the UEBMI patients could incur higher OOP expenses and longer hospital stays [39]. Furthermore, a large proportion of patients covered by the URBMI were unemployed and children, with lower education levels than the UEBMI patients. Education level was considered an important factor which would affect the ALOS for stroke inpatients [36]. There were significant regional variations in education level, with people in eastern China having the highest education level, followed by the central and western regions. These regional education level differences probably interacted with the type of insured patient to contribute to inequity in UEBMI-URBMI healthcare utilization and hospital expenses.

Eastern China was the main source of inequity

Figures 1, 2 and 3 displays the inequity in healthcare utilization and medical costs. We found that the internal differences within regions were major factors contributing to inequity in stroke patients in regard to healthcare utilization and health service expenses. Internal differences in the eastern region accounted for the largest part of the Theil index. When the gap of socio-economic development level between the richer eastern region and poorer western and northern regions was significant, it seemed counter intuitive that the richest region had the greatest inequity in healthcare utilization and health service expenses. The coastal areas and strong economic zones in eastern China had advantages of export-linked and foreign investment industry and enhanced infrastructure, and benefited most from economic policy reforms that transformed China’s economy, but that would possibly widen the economic gap between different cities in eastern China. Differences among cities in the central and western provinces were relatively smaller than within the eastern region. Therefore, socio-economic factors may be an important reason for the greater healthcare inequity within the eastern region. Another possible reason for the inequalities within the eastern and between the eastern and other regions was healthcare resource allocation. Previous studies reported that the eastern region had been experiencing the worst equity in health resource allocation [40], which was reflected in inequities in healthcare delivery. We recommend that the government should not only make policies to improve the medical system in central and western regions, but also take the less developed provinces and prefectures in eastern China into account.

The health resource factors and enabling factors had significant influence on stroke patients’ medical costs and OOP expenses

Our results demonstrated that the number of actual open beds per 1000 residents at the provincial level which measured health resource factor had a significant negative impact on the medical costs and OOP expenses both in the UEBMI and URBMI group. While the number of healthcare staff per 1000 residents was positively associated with medical costs and OOP expenses both in these two groups. Health resources are considered as one of the important indicators reflecting the capacity of the healthcare system, and can determine the access to health services from the supply side. Previous studies have identified a positive relationship between health care and health resources [41, 42]. We believe that more staff improved patient’s healthcare utilization and caused higher expenses, which can be explained by Physician-Induced demand theory. In terms of the negative association between beds and medical costs, theoretically, more beds could significantly reduce the average fixed cost of a bed in a hospital, as well improve the ability of a hospital to generate revenue. We speculate that hospitals with more beds were faced with lower financial risk, thus, induce demand was less likely to happen. In addition, under China’s medical system, hospitals with more beds generally had stronger medical technology, which contributed to fewer medical costs for patients [43]. Thus, both the UEBMI and URBMI patients had fewer medical costs and OOP expenditure when a province equipped with more beds.

The province-level reimbursement rate which measured enabling factors was negatively associated with OOP expense both in UEBMI and URBMI group, and also had a negative influence on medical costs in URBMI group. That was consistent with findings in prior studies [44]. Higher reimbursement rate means stronger financial protection for patients. When protected by a strong enough health insurance system, patients are given the capacity and chance to utilize equal medical services, especially for vulnerable groups. The urban employment rate, which measured enabling factor, had a positive influence on medical costs in the URBMI group. Higher urban employment rate means more urban families had stable income, who are more likely to utilize health services and had higher medical costs, but less likely to incur catastrophic health expenditure [45]. Similarly, Lee’s study revealed that due to lack of proper financial safety net, patients could reduce healthcare utilization and non-adherence to treatment because of unemployment [46]. In terms of the negative impact of provincial average schooling years on medical costs and OOP expenses both in the UEBMI and URBMI group, there were several possible reasons behind that. First, with the growth of education attainment years, people’s awareness of maintaining physical and mental health has critically improved, thus people were more likely to take health-related behavior such as smoking cessation and keeping exercise. People with healthy bodies were considered easier to recover from illness and had fewer medical costs [47]. Second, with better education attainment, we speculate that people knew more about the National Health Insurance Directory, which endowed them with stronger ability to identify and refuse parts of health services uncovered in the Directory, and utilize more services covered in the Directory (costs of health services covered in the Directory will be compensated by insurance scheme) and causing fewer OOP expense. Third, better education attainment could possibly make people less likely to fall into the trap of induced demand of hospitals. And overtreatment due to demand side is also less likely to happen [48]. In addition, we found that the URBMI group was more sensitive to education attainment year than the UEBMI group when it comes to the impact on medical costs and OOP expenses. We speculate that people with UEBMI had an overall better education attainment than people with URBMI. Consequently, the marginal effect of education attainment year for the UEBMI group was weaker.

However, we found no statistical association between all indictors and healthcare utilization in this study. This may be because we selected only ALOS to represent stroke patients’ healthcare utilization at provincial level. Although we have known that health resource factors, enabling factors and economic factors have significant influence on healthcare utilization from literatures [25, 49], we didn’t have enough evidence to guarantee these indicators measuring province-level ALOS appropriately.

Limitations

This study has a number of limitations. Firstly, our data applies to healthcare utilization and medical costs of urban stroke inpatients, findings might not be generalizable to the whole stroke patient population in China. Secondly, due to data limitations, we used ALOS to reflect healthcare utilization of stroke patients, but healthcare utilization based on need and demand cannot be easily divided. Therefore, the results should be interpreted with care. Thirdly, our data was from 2013 to 2016 which would be a little delayed. After 2016, URBMI has emerged with the new rural cooperative medical insurance (insurance mainly cover rural residents) which has greatly improved the equity between rural and urban aeras in China. Since gaps between URBMI and UEBMI still exists, we believe our research could contribute to further improvement on equity in stroke patients in regard to healthcare utilization.

Conclusion

Under the fragmented health insurance system in China, there were significant disparities in healthcare utilization and medical costs within and between regions for stroke patients from the year 2013 to 2016. The internal differences in the eastern region which made the highest contribution to the Theil index were relatively larger than other regions. And the UEBMI group enjoyed greater equity in healthcare utilization and medical costs than the URBMI group. Health resources factors represented by the number of hospital beds per 1000 residents and the number of healthcare staff per 1000 residents, enabling factors represented by education attainment years and reimbursement rate, and economic factor represented by GDP per capita contributed to the identified unfairness of medical costs and OOP expenses. This study could be a model for future studies which intend to investigate fairness of costs for other illness interests. It is essential for policy makers to take effective measures to reduce inequity for stroke patients, such as consolidating the fragmented health insurance system at national level, providing equal benefit package and financial protection for both UEBMI and URBMI patients in different regions. Improving education attainment, offering equal access to healthcare, allocating health resources reasonably and balancing health services prices in different regions can also reduce patients’ medical costs and improve equity.

Availability of data and materials

The data that support the findings of this study are available from China Health Insurance Research Association, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of China Health Insurance Research Association.

Abbreviations

UEBMI:

Urban Employee Basic Medical Insurance scheme

URBMI:

Urban Resident Basic Medical Insurance scheme

OOP:

out-of-pocket

ALOS:

average length of stay

Beds:

actual open beds per 1000 residents

Staff:

the number of healthcare staff per 1000 residents

References

  1. Longde W, Jianmin L, Yi Y, Bin P, Yilong W. The Prevention and Treatment of Stroke Still Face Huge Challenges——Brief Report on Stroke Prevention and Treatment in China, 2018. Chin Circ J. 2019;34(2):248.

  2. Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–11. https://doi.org/10.1055/s-0038-1649503.

    Article  Google Scholar 

  3. Zhu D, Shi X, Nicholas S, Chen S, Ding R, Huang L, et al. Medical service utilization and direct medical cost of stroke in urban China. Int J Health Policy Manag. 2020. https://doi.org/10.34172/ijhpm.2020.111.

  4. Zhang H, Yin Y, Zhang C, Zhang D. Costs of hospitalization for stroke from two urban health insurance claims data in Guangzhou City, southern China. BMC Health Serv Res. 2019;19(1):671. https://doi.org/10.1186/s12913-019-4530-2.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Huo X, Jiang B, Chen Z, Ru X, Sun H, Sun D, et al. Difference of hospital charges for stroke inpatients between hospitals with different levels and therapeutic modes in Beijing, China. Int J Neurosci. 2017;127(9):752–61. https://doi.org/10.1080/00207454.2016.1247075.

    Article  PubMed  Google Scholar 

  6. Tang S, Meng Q, Chen L, Bekedam H, Evans T, Whitehead M. Tackling the challenges to health equity in China. Lancet. 2008;372(9648):1493–501. https://doi.org/10.1016/S0140-6736(08)61364-1.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Chen M, Zhao Y, Si L. Who pays for health care in China? The case of Heilongjiang province. PLoS One. 2014;9(10):e108867. https://doi.org/10.1371/journal.pone.0108867.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wang Z, Chen Y, Pan T, Liu X, Hu H. The comparison of healthcare utilization inequity between URRBMI and NCMS in rural China. Int J Equity Health. 2019;18(1):90. https://doi.org/10.1186/s12939-019-0987-1.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Dong K. Medical insurance system evolution in China. China Econ Rev. 2009;20(4):591–7. https://doi.org/10.1016/j.chieco.2009.05.011.

    Article  Google Scholar 

  10. Fang H, Eggleston K, Hanson K, Wu M. Enhancing financial protection under China’s social health insurance to achieve universal health coverage. Bmj. 2019;365.

  11. W Y, H F, AT C, T Z, W J, R X, et al. 10 years of health-care reform in China: progress and gaps in Universal Health Coverage. Lancet (London, England). 2019;394(10204):1192–204.

    Article  Google Scholar 

  12. Zhu K, Zhang L, Yuan S, Zhang X, Zhang Z. Health financing and integration of urban and rural residents' basic medical insurance systems in China. Int J equity in Health. 2017;16(1):194.

  13. Fang H, Meng Q, Rizzo JA. Do different health insurance plans in China create disparities in health care utilization and expenditures. Int J Appl Econ. 2014;11(1):1–18.

    Google Scholar 

  14. Meng Q, Fang H, Liu X, Yuan B, Xu J. Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet (London, England). 2015;386(10002):1484–92.

    Article  Google Scholar 

  15. Xin XX, Zhao L, Guan XD, Shi LW. Determinants and equity evaluation for health expenditure among patients with rare diseases in China. Chin Med J. 2016;129(12):1387–93. https://doi.org/10.4103/0366-6999.183425.

    Article  PubMed  Google Scholar 

  16. Mercier G, Pastor J, Clément V, Rodts U, Moffat C, Quéré I. Out-of-pocket payments, vertical equity and unmet medical needs in France: a national multicenter prospective study on lymphedema. PLoS One. 2019;14(5):e0216386. https://doi.org/10.1371/journal.pone.0216386.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yahyavi Dizaj J, Anbari Z, Karyani AK, Mohammadzade Y. Targeted subsidy plan and Kakwani index in Iran health system. J Educ Health Promot. 2019;8:98.

    PubMed  PubMed Central  Google Scholar 

  18. Woldemichael A, Takian A, Akbari Sari A, Olyaeemanesh A. Inequalities in healthcare resources and outcomes threatening sustainable health development in Ethiopia: panel data analysis. BMJ Open. 2019;9(1):e022923. https://doi.org/10.1136/bmjopen-2018-022923.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Yao Q, Liu C, Ferrier JA, Liu Z, Sun J. Urban-rural inequality regarding drug prescriptions in primary care facilities - a pre-post comparison of the National Essential Medicines Scheme of China. Int J Equity Health. 2015;14(1):58. https://doi.org/10.1186/s12939-015-0186-7.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Krishnamoorthy Y, Majella MG, Rajaa S. Equity in coverage of maternal and newborn care in India: evidence from a nationally representative survey. Health Policy Plan. 2020;35(5):616–23. https://doi.org/10.1093/heapol/czaa020.

    Article  PubMed  Google Scholar 

  21. Hajizadeh M, Alam N, Nandi A. Social inequalities in the utilization of maternal care in Bangladesh: have they widened or narrowed in recent years? Int J Equity Health. 2014;13(1):120. https://doi.org/10.1186/s12939-014-0120-4.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Silver EW. Economics and Information Theory. J Oper Res Soc. 1967;18(3):328.

    Article  Google Scholar 

  23. Tao Y, Henry K, Zou Q, Zhong X. Methods for measuring horizontal equity in health resource allocation: a comparative study. Heal Econ Rev. 2014;4(1):10. https://doi.org/10.1186/s13561-014-0010-x.

    Article  Google Scholar 

  24. Cao X, Bai G, Cao C, Zhou Y, Xiong X, Huang J, et al. Comparing Regional Distribution Equity among Doctors in China before and after the 2009 Medical reform policy: a data analysis from 2002 to 2017. Int J Environ Res Public Health. 2020;17(5):1520.

  25. Wu Y, Zhang L, Liu X, Ye T, Wang Y. Geographic variation in health insurance benefits in Qianjiang District, China: a cross-sectional study. Int J Equity Health. 2018;17(1):20. https://doi.org/10.1186/s12939-018-0730-3.

    Article  PubMed  PubMed Central  Google Scholar 

  26. S S, B Y, L Z, G C, W Z, Z H, et al. Increased Inequalities in Health Resource and Access to Health Care in Rural China. Int J Environ Res Public Health. 2018;16(1):49.

  27. Tanou M, Kamiya Y. Assessing the impact of geographical access to health facilities on maternal healthcare utilization: evidence from the Burkina Faso demographic and health survey 2010. BMC Public Health. 2019;19(1):838. https://doi.org/10.1186/s12889-019-7150-1.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Oshio T, Kan M. Educational level as a predictor of the incidences of non-communicable diseases among middle-aged Japanese: a hazards-model analysis. BMC Public Health. 2019;19(1):852. https://doi.org/10.1186/s12889-019-7182-6.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Fandi L. Research on equalization of basic medical and health services in urban and rural areas: Southwestern university of finance and economics; 2018.

  30. Shifa X, Yannan Z, Xianzhi F, Changqing S. Analysis of the Fairness of Medical Service Utilization of Chinese Residents Based on Concentration Index. Chinese Journal of Social Medicine. 2019;36(4):416-20.

  31. Bo W, Feng C, Peng-li Z, Yuan X, Xin H, Juan P, et al. Exploration and practice of the performance evaluation reform of public top three hospitals. Health Econ Res. 2020;03:66–8.

    Google Scholar 

  32. Specogna AV, Turin TC, Patten SB, Hill MD. Hospital treatment costs and length of stay associated with hypertension and multimorbidity after hemorrhagic stroke. BMC Neurol. 2017;17(1):158. https://doi.org/10.1186/s12883-017-0930-2.

    Article  PubMed  PubMed Central  Google Scholar 

  33. L P, J W, Z W, X W, Z C, J L, et al. Geographic variations and potential macro-environmental exposure of hypertension: from the China hypertension survey. J Hypertens. 2020 May;38(5):829-838.

  34. Longde W, Qunan M, Zongjiu Z. Chinese stroke prevention report 2018: people health press; 2018.

  35. LC H, YH H, SF S. Exploring the impact of intravenous thrombolysis on length of stay for acute ischemic stroke: a retrospective cohort study. BMC Health Serv Res. 2015;15:404.

    Article  Google Scholar 

  36. Manwani B, Rath S, Lee NS, Staff I, Stretz C, Modak J, et al. Early magnetic resonance imaging decreases hospital length of stay in patients with ischemic stroke. J Stroke Cerebrovasc Dis. 2019;28(2):425–9. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.10.015.

    Article  PubMed  Google Scholar 

  37. Xin Z. Comparative analysis of the Equity of Health Services Utilizationunder Different Region residents: Shihezi university; 2016.

  38. Wang Z, Li X, Chen M, Si L. Social health insurance, healthcare utilization, and costs in middle-aged and elderly community-dwelling adults in China. Int J Equity Health. 2018;17(1):17. https://doi.org/10.1186/s12939-018-0733-0.

    Article  PubMed  PubMed Central  Google Scholar 

  39. MJ K, H L, EH K, MH C, DW S, JM Y, et al. Disparity in health screening and health utilization according to economic status. Korean J Fam Med. 2017;38(4):220–5.

    Article  Google Scholar 

  40. Liu W, Liu Y, Twum P, Li S. National equity of health resource allocation in China: data from 2009 to 2013. Int J Equity Health. 2016;15(1):68. https://doi.org/10.1186/s12939-016-0357-1.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Chen Y, Yin Z, Xie Q. Suggestions to ameliorate the inequity in urban/rural allocation of healthcare resources in China. Int J Equity Health. 2014;13(1):34. https://doi.org/10.1186/1475-9276-13-34.

    Article  PubMed  PubMed Central  Google Scholar 

  42. WHO Guidelines Approved by the Guidelines Review Committee. Increasing Access to Health Workers in Remote and Rural Areas Through Improved Retention: Global Policy Recommendations. Geneva: World Health Organization Copyright © 2010, World Health Organization; 2010.

    Google Scholar 

  43. Liu H, Zhu D, Song B, Jin J, Liu Y, Wen X, et al. Cost-effectiveness of an intervention to improve the quality of nursing care among immobile patients with stroke in China: a multicenter study. Int J Nurs Stud. 2020;110:103703. https://doi.org/10.1016/j.ijnurstu.2020.103703.

    Article  PubMed  Google Scholar 

  44. Dai T, Hu HP, Na X, Li YZ, Wan YL, Xie LQ. Effects of new rural cooperative medical scheme on medical service utilization and medical expense control of inpatients: a 3-year empirical study of Hainan Province in China. Chin Med J. 2016;129(11):1280–4. https://doi.org/10.4103/0366-6999.182842.

    Article  PubMed  Google Scholar 

  45. Choi JW, Kim TH, Jang SI, Jang SY, Kim WR, Park EC. Catastrophic health expenditure according to employment status in South Korea: a population-based panel study. BMJ Open. 2016;6(7):e011747. https://doi.org/10.1136/bmjopen-2016-011747.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Lee HY, Kondo N, Oh J. Medical expenditure and unmet need of the pre-elderly and the elderly according to job status in Korea: are the elderly indeed most vulnerable? PLoS One. 2018;13(3):e0193676. https://doi.org/10.1371/journal.pone.0193676.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Faiz KW, Labberton AS, Thommessen B, Rønning OM, Barra M. Stroke-related knowledge and lifestyle behavior among stroke survivors. J Stroke Cerebrovasc Dis. 2019;28(11):104359. https://doi.org/10.1016/j.jstrokecerebrovasdis.2019.104359.

    Article  PubMed  Google Scholar 

  48. Gamra H, Murin J, Chiang CE, Naditch-Brûlé L, Brette S, Steg PG. Use of antithrombotics in atrial fibrillation in Africa, Europe, Asia and South America: insights from the international RealiseAF survey. Arch Cardiovasc Dis. 2014;107(2):77–87. https://doi.org/10.1016/j.acvd.2014.01.001.

    Article  PubMed  Google Scholar 

  49. Hou J, Ke Y. Addressing the shortage of health professionals in rural China: issues and progress comment on "have health human resources become more equal between rural and urban areas after the new reform?". Int J Health Policy Manag. 2015;4(5):327–8. https://doi.org/10.15171/ijhpm.2015.57.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. School of Management, Beijing University of Chinese Medicine, No. 11, Bei San Huan Dong Lu, Chaoyang District, Beijing, 100029, People’s Republic of China

    Yong Yang, Zhengwei Huang, Xiaoping Chen & Xuefeng Shi

  2. Medical Device Regulatory Research and Evaluation Center, West China Hospital, Sichuan University, Chengdu, China

    Yong Yang

  3. Australian National Institute of Management and Commerce, 1 Central Avenue Australian Technology Park, Eveleigh Sydney, NSW, 2015, Australia

    Stephen Nicholas

  4. School of Economics and School of Management, Tianjin Normal University, Tianjin, China

    Stephen Nicholas

  5. Guangdong Institute for International Strategies, Guangdong University of Foreign Studies, Guangzhou, China

    Stephen Nicholas

  6. Newcastle Business School, University of Newcastle, Newcastle, Australia

    Stephen Nicholas

  7. University of Liverpool Management School, University of Liverpool, Liverpool, L697ZH, UK

    Elizabeth Maitland

  8. China Health Insurance Research Association, Beijing, China

    Yong Ma

  9. National Institute of Traditional Chinese Medicine Strategy and Development, Beijing University of Chinese Medicine, Beijing, China

    Xuefeng Shi

Authors
  1. Yong Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Nicholas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elizabeth Maitland
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhengwei Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoping Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yong Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xuefeng Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YY and XFS participated in the design of this study, analyzed data and drafted the original manuscript. SN and EM participated in interpretation of data and critically revised the paper; ZWH and XPC analyzed the data and drafted the manuscript, YM collected research data and critically revised the manuscript, all authors have read and approved the final manuscript.

Corresponding author

Correspondence to Xuefeng Shi.

Ethics declarations

Ethics approval and consent to participate

Since the claims data we used was an anonymized and secondary database, human participants are not directly involved in the study, the informed consent was exempted. This study was approved by the Ethics Committee of Beijing University of Chinese medicine (No.2019BZHYLL0201).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, Y., Nicholas, S., Maitland, E. et al. An equity evaluation in stroke inpatients in regard to medical costs in China: a nationwide study. BMC Health Serv Res 21, 425 (2021). https://doi.org/10.1186/s12913-021-06436-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-021-06436-x

Keywords

BMC Health Services Research

ISSN: 1472-6963

Contact us